Sundar PichaiSundar Pichai earned $164M in 2023
U

Emil D. Kakkis, M.D., Ph.D.

Founder and Ex-CEO of Ultragenyx Pharmaceutical

Education

M.D. and Ph.D. from the University of California, San Francisco

Field of Expertise

Healthcare & Life Sciences - Medicine

Born

July 1, 1968 - 56 years ago

Economy Sector

Healthcare

Tenure

8 years 11 months (Oct 2014 - Sep 2023)

Previous Experience

Founder and CEO of Ultragenyx Pharmaceutical Inc.

Emil D. Kakkis, M.D., Ph.D., is the co-founder and CEO of Ultragenyx Pharmaceutical Inc., a company dedicated to developing treatments for rare diseases. Dr. Kakkis has a strong medical background with an M.D. and Ph.D. from the University of California,...

Year

2023

Total Compensation

$2.07M

Salary

$823.69K

Board Justification

The compensation philosophy aims to attract and retain a highly-skilled team of executives, aligning their interests with those of stockholders by rewarding performance that increases stockholder value.

Bonus

$622.70K

Board Justification

The bonus for fiscal 2023 was based solely on corporate performance, with a total achievement score of 94% resulting in a bonus of 75% of base salary.

Other

$622.66K

Board Justification

This includes 401(k) matching contributions and other benefits.

Restricted Stock

$0.00(0 RSU)

Board Justification

No stock grants were vested in 2023; only stock options and RSUs are reported, which are not included in total compensation calculations.

Performance Metrics

The performance metrics for 2023 included corporate goals related to revenue growth, clinical trial enrollment, and operational efficiency, with an overall achievement score of 94%.